Granules India Ltd.

“Manufacturing excellence, process innovation, and regulatory expertise” are some of the statements made by the generics manufacturing firm Granules India on its website, but the recent six observat

India’s interim budget 2024 furthers the government’s push for self-reliance with a hike in the allocation for production-linked incentive (PLI) schemes related to pharmaceuticals, support for green b

Diversified major Japanese foods firm Ajinomoto Co., Inc. is to acquire the US gene therapy-focused contract development and manufacturing organization (CDMO) Forge Biologics for approximately $554m

India’s compliance-quality issues, especially if you look beyond the frontline firms, are real - so, let’s not simply sweep it under the carpet. The problem is multidimensional and there are economic